Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia

It is unknown whether bacterial bloodstream infections (BSIs) are commonly caused by single organisms or mixed microbial populations. We hypothesized that contemporaneous carbapenem-resistant Klebsiella pneumoniae (CRKP) strains from blood cultures of individual patients are genetically and phenotypically distinct. We determined short-read whole-genome sequences of 10 sequence type 258 (ST258) CRKP strains from blood cultures in each of 6 patients (Illumina HiSeq). Strains clustered by patient by core genome and pan-genome phylogeny. In 5 patients, there was within-host strain diversity by gene mutations, presence/absence of antibiotic resistance or virulence genes, and/or plasmid content. Accessory gene phylogeny revealed strain diversity in all 6 patients. Strains from 3 patients underwent long-read sequencing for genome completion (Oxford Nanopore) and phenotypic testing. Genetically distinct strains within individuals exhibited significant differences in carbapenem and other antibiotic responses, capsular polysaccharide (CPS) production, mucoviscosity, and/or serum killing. In 2 patients, strains differed significantly in virulence during mouse BSIs. Genetic or phenotypic diversity was not observed among strains recovered from blood culture bottles seeded with index strains from the 3 patients and incubated in vitro at 37°C. In conclusion, we identified genotypic and phenotypic variant ST258 CRKP strains from blood cultures of individual patients with BSIs, which were not detected by the clinical laboratory or in seeded blood cultures. The data suggest a new paradigm of CRKP population diversity during BSIs, at least in some patients. If validated for BSIs caused by other bacteria, within-host microbial diversity may have implications for medical, microbiology, and infection prevention practices and for understanding antibiotic resistance and pathogenesis. IMPORTANCE The long-standing paradigm for pathogenesis of bacteremia is that, in most cases, a single organism passes through a bottleneck and establishes itself in the bloodstream (single-organism hypothesis). In keeping with this paradigm, standard practice in processing positive microbiologic cultures is to test single bacterial strains from morphologically distinct colonies. This study is the first genome-wide analysis of within-host diversity of Klebsiella pneumoniae strains recovered from individual patients with bloodstream infections (BSIs). Our finding that positive blood cultures comprised genetically and phenotypically heterogeneous carbapenem-resistant K. pneumoniae strains challenges the single-organism hypothesis and suggests that at least some BSIs are caused by mixed bacterial populations that are unrecognized by the clinical laboratory. The data support a model of pathogenesis in which pressures in vivo select for strain variants with particular antibiotic resistance or virulence attributes and raise questions about laboratory protocols and treatment decisions directed against single strains.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

mBio - 13(2022), 6 vom: 20. Dez., Seite e0290622

Sprache:

Englisch

Beteiligte Personen:

Cheng, Shaoji [VerfasserIn]
Fleres, Giuseppe [VerfasserIn]
Chen, Liang [VerfasserIn]
Liu, Guojun [VerfasserIn]
Hao, Binghua [VerfasserIn]
Newbrough, Anthony [VerfasserIn]
Driscoll, Eileen [VerfasserIn]
Shields, Ryan K [VerfasserIn]
Squires, Kevin M [VerfasserIn]
Chu, Ting-Yu [VerfasserIn]
Kreiswirth, Barry N [VerfasserIn]
Nguyen, M Hong [VerfasserIn]
Clancy, Cornelius J [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Beta-Lactamases
Blood culture
Bloodstream infection
Carbapenem resistance
Carbapenems
EC 3.5.2.6
Journal Article
Klebsiella pneumoniae
Sequence type 258
Whole-genome sequence
Within-host diversity

Anmerkungen:

Date Completed 28.02.2023

Date Revised 12.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1128/mbio.02906-22

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM34957927X